In March a U.S. Food and Drug Administration review panel unanimously recommended approving the device for the American market as well. To do so, the firm will have to persuade insurers to cover the cost. Harkness reports that the Netherlands has already requested a study comparing the long-term cost and benefits of the implant with those of destructive surgery. U.S. insurers may follow suit. Ultimately, the question may be moot.
Any side effects caused by a halamotomy are irreversible.
Sherman says he doesn't know whether his insurance will cover his second implant. Whatever it costs, it's worth it.